secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYOMO, INC. (MYO)
CIK:        0001369290
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0000950170-23-060269
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myomo Q3 record product revenue $5.0M, up 27% YoY; net loss narrows to $2.0M
----------------------------------------------------------------------------

- Total revenue $5.1M (+28% YoY); product revenue $5.0M (+27%) on 119 units (+37%).
- Net loss $2.0M ($0.06/share) vs $2.8M loss ($0.40/share) in Q3 2022; adjusted EBITDA ($1.7M).
- Received 156 MyoPro orders/authorizations (+20%); pipeline hits 1,046 candidates (+28%).
- CMS reclassifies MyoPro as brace effective Jan 1, 2024; proposed fee rates $31,745 and $62,457.
- First Medicare Part B rental payments received from all four DME MACs; six claims filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369290/000095017023060269/0000950170-23-060269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369290/000095017023060269/myo-20231107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-060269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer